Published: 2021-04-10


Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases
Chung-Tso Chen, Yen-Chieh Wang, Chih-Ming Lin
Division of Urology, Department of Surgery, Cathay General Hospital, Taipei, Taiwan
Am J Case Rep 2021; 22:e929758
DOI: 10.12659/AJCR.929758
BACKGROUND:
Primary aldosteronism, also known as Conn’s syndrome, is a clinical condition caused by excessive production of aldosterone. The classic presenting signs of primary aldosteronism are hypertension and hypokalemia. However, rhabdomyolysis induced by severe hypokalemia is a rare manifestation of primary aldosteronism. There were only a few cases presented in the English literature over the last 4 decades.
CASE REPORT:
We present 2 cases, a 53-year-old man and a 46-year-old man, with severe hypokalemia-induced rhabdomyolysis caused by adrenal tumor-related primary aldosteronism. Both of these patients were under medical treatment with oral anti-hypertension drug for hypertension, but were poorly controlled. They both presented to the Emergency Department with muscle weakness and pain. Laboratory testing showed elevated creatinine phosphokinase (CPK) and low serum potassium levels. Hypokalemia-induced rhabdomyolysis was suspected. A further endocrine survey showed low PRA (plasma renin activity) and high aldosterone levels, finding which are compatible with primary aldosteronism. Computed tomography (CT) was arranged for further evaluation, and adrenal tumors were found in both cases. Both patients underwent robotic-assisted laparoscopic adrenalectomy. In both cases, there was no recurrence of hypokalemia without potassium supplementation, and their hypertension was under better control at further follow-up visits.
CONCLUSIONS:
Hypokalemic rhabdomyolysis is a rare manifestation of primary aldosteronism. It might be difficult to making a diagnosis when rhabdomyolysis and severe hypokalemia are the first manifestations in patients with primary aldosteronism. The use of diuretics for hypertension treatment might be a risk factor for extremely low potassium levels, which can induce rhabdomyolysis in patients with primary aldosteronism.
Keywords: Adrenal Gland Neoplasms, Adrenalectomy, Adrenocortical Hyperfunction, Hyperaldosteronism, Hypokalemia
Related articles (0)
Published: 2021-04-10


Hodgkin Lymphoma-Associated Superior Vena Cava Syndrome: A Case Report and Review of the Literature
Department of Internal Medicine, Saint Agnes Healthcare, Baltimore, MD, USA
Ruoning Ni, Mahmoud Amr, Abhishek Kalla
Am J Case Rep 2021; 22:e929437
DOI: 10.12659/AJCR.929437
Published: 2021-04-09


False-Positive Nonstructural Protein 1 Antigen in a Patient with Philadelphia Chromosome-Positive Acute L...
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Supat Chamnanchanunt, Pravinwan Thungthong, Asrinda Abdulkanan, Chajchawan Nakhakes
Am J Case Rep 2021; 22:e928865
DOI: 10.12659/AJCR.928865